A new paradigm of cardiohematological monitoring in patients with chronic myeloid leukemia taking tyrosine kinase inhibitors. Ukrainian Journal of Cardiology, [S. l.], v. 29, n. 1-2, p. 72–86, 2022. DOI: 10.31928/1608-635X-2022.1-2.7286. Disponível em: https://ucardioj.com.ua/index.php/UJC/article/view/300.. Acesso em: 12 apr. 2024.